Point of Care
FDA Cleared Sepsis Test Becomes First in New Class of ED-Focused Diagnostic Tools
Cytovale’s (San Francisco, CA, USA) IntelliSep sepsis test is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis and contribute to rapid life-saving decisions. The groundbreaking diagnostic tool provides test results in less than 10 minutes, helping clinicians to recognize sepsis and supporting critical time-sensitive clinical decisions. More...23 Jan 2023
Multi-Disease POC Breathalyzer Sniffs Out Infections and Monitors Patients on Ventilator
A novel diagnostic testing device uses a patient's breath to diagnose various forms of cancer, COVID-19 and related variants, acute respiratory distress syndrome (ARDS), sepsis, and other acute and chronic inflammatory diseases. More...19 Jan 2023
Rapid Diagnostic Platform Delivers Up To 30 Results from Single Drop of Body Fluid within 15 Minutes
A next-generation rapid diagnostic platform that is capable of conducting multiplex testing in a single biochip within 15 minutes could become a game changer in the point-of-care testing (POCT) market. More...18 Jan 2023
World’s Most Child-Friendly Respiratory Swab Addresses Major Challenge of Testing Reluctance
One of the pandemics' major challenges has been testing reluctance created by the fear, anxiety and discomfort associated with traditional combined throat and nose swabs. Now, the world’s first nasal swab developed specifically for children features a unique design that addresses this challenge. More...09 Jan 2023
POC Test Detects and Differentiates Between Upper Respiratory Infections Caused by Influenza and SARS-CoV-2
A fast, polymerase chain reaction (PCR) device can detect and differentiate between upper respiratory infections caused by Influenza (Flu) A & B, and SARS-CoV-2 (COVID-19). More...04 Jan 2023
Advanced Hematology Analyzer Brings Simplicity and Efficiency to Decentralized Healthcare Facilities
Diatron (Budapest, Hungary) has announced the launch of Aquarius 3, its latest IVD hematology analyzer for Complete Blood Count testing that is all set to bring unrivaled simplicity and efficiency to the decentralized market segment. More...02 Jan 2023
In Other News
Extremely Sensitive Fluorescence Lateral Flow Reader Detects Even Low Positives Results
POC Assay Could Diagnose Acute Coronary Syndrome in 3-5 Minutes
New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
POC Molecular TB Test Could Enable Clinicians to Begin Appropriate Treatment Immediately
Early Sepsis Recognition Platform Could Identify Pre-Symptomatic Patients at POC Using Culture-Free Diagnostic Test
New Digital Platform Technology Aims to Disrupt 50-Year-Old PCR Testing for Similar-Symptom Pathogens
Hand-Held POC Biosensor Quickly and Accurately Detects Oral Cancer
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Rapid Credit Card-Sized UTI Diagnostic Test Detects Four Major Uropathogens from Urine Drop
Novel POC Hemolysis System Improves Patient Care, Reduces Workload for Emergency Departments and ICUs
Portable qPCR Platform Enables Faster, Better, Low-Cost Near-Patient Molecular Diagnosis
Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes
New Wearable Patient Monitoring System Refines Clinician’s Workflow to Track Patient Conditions
Next-Gen POC Whole Blood Hemostasis System Recognizes Specific Needs of EDs and ORs
Handheld Lab to Enable Faster, Cheaper Point-of-Need Bacterial Infection Identification
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
Breakthrough POC Diagnostic Technology Detects Brain Abnormalities Prior to Symptoms
Advantech Presents Latest Range of Point-of-Care Solutions at MEDICA 2022
EKF Showcases POCT Connectivity Solutions at MEDICA 2022
LumiraDx Presents its POC Diagnostics Platform and Broad Test Menu at MEDICA 2022
Vedalab Presents Innovative Reagents and Instruments at MEDICA 2022
Nova Biomedical Exhibits IVD Testing Solutions for POC and Critical Care at MEDICA 2022
One-Time Blood Test Predicts Which Hospitalized COVID-19 Patients Will Grow Worse
The HospiMedica Point-of-Care Testing channel provides reporting on clinical/medical testing that is performed at the patient's side, near the patient and outside of the clinical laboratory. This would include testing provided by healthcare professionals and remote/field personnel and does not require processing by a central laboratory.